Harris, L N <br/><br/>
Comparison of methods of measuring HER-2 in metastatic breast cancer patients treated with high-dose chemotherapy.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Mar 2001 
 - 1698-706 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2001.19.6.1698  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents, Alkylating--pharmacology<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Biomarkers, Tumor--analysis<br/>Breast Neoplasms--drug therapy<br/>Disease-Free Survival<br/>Drug Resistance, Neoplasm<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Genes, erbB-2--genetics<br/>Humans<br/>In Situ Hybridization, Fluorescence<br/>Middle Aged<br/>Predictive Value of Tests<br/>Prognosis<br/>Receptor, ErbB-2--analysis<br/>Retrospective Studies